Hainan Shuangcheng Pharmaceuticals Co., Ltd., commonly referred to as Shuangcheng Pharma, is a prominent player in the pharmaceutical industry, headquartered in Hainan, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across various regions in China and beyond, Shuangcheng Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of APIs and formulations that cater to both domestic and international markets. Notably, Shuangcheng has achieved several industry certifications, underscoring its dedication to maintaining rigorous quality standards. As a result, it has secured a competitive position within the global pharmaceutical landscape, recognised for its reliability and excellence in service delivery.
How does Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hainan Shuangcheng Pharmaceuticals Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Hainan Shuangcheng Pharmaceuticals is approaching climate commitments within the pharmaceutical industry. The absence of reported emissions and targets may reflect a need for enhanced transparency and accountability in their environmental practices. In the context of the pharmaceutical sector, companies are increasingly expected to adopt science-based targets and engage in sustainability initiatives to mitigate climate impact. Hainan Shuangcheng Pharmaceuticals may benefit from aligning with industry standards and best practices to improve their environmental performance and contribute to global climate goals.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.